Pulse Biosciences Updates on CellFX Program Regulatory and Scientific Analyze Development
HAYWARD, Calif.–(Business WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE) (“Pulse Biosciences” or the “Company”), a novel bioelectric
Updates
Eiger BioPharmaceuticals Updates on 2020 Progress and 2021 Designs
PALO ALTO, Calif., Jan. 7, 2021 /PRNewswire/ — Eiger BioPharmaceuticals, Inc (Nasdaq:EIGR), a industrial-stage biopharmaceutical firm